The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?
This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.
The Conversation ·